Tenax Therapeutics (TENX) Asset Utilization Ratio (2011 - 2013)
Tenax Therapeutics' (TENX) quarterly Asset Utilization Ratio came in at 0.38 in Q2 2013, up 438.2% year-on-year from 0.07 in Q2 2012, and up 14.6% quarter-over-quarter from 0.33 in Q1 2013.
Tenax Therapeutics (TENX) Asset Utilization Ratio (2011 - 2013) Analysis & Trends
Tenax Therapeutics has disclosed Asset Utilization Ratio across 3 years of filings, most recently posting 0.38 for Q2 2013.
- Asset Utilization Ratio for Q2 2013 came in at 0.38, up 438.2% year-over-year; the trailing twelve-month figure through Apr 2013 was 0.38 (up 438.2% YoY), and the FY2013 annual result was 0.33, up 265.3% from the prior year.
- Asset Utilization Ratio came in at 0.38 for Q2 2013 at Tenax Therapeutics, up from 0.33 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.38 in Q2 2013 to a low of 0.03 in Q3 2011.
- The 3-year median for Asset Utilization Ratio is 0.1 (2012), against an average of 0.16.
- Peak annual rise in Asset Utilization Ratio reached 562.67% in 2012, while the deepest fall reached 381.74% in 2012.
- Tenax Therapeutics' Asset Utilization Ratio stood at 0.04 in 2011, then soared by 562.67% to 0.24 in 2012, then soared by 61.99% to 0.38 in 2013.
- The last three Asset Utilization Ratio figures came in at 0.38 (Q2 2013), 0.33 (Q1 2013), and 0.24 (Q4 2012), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 0.55 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.60 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 1,422.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Tenax Therapeutics | 110.80 Mn | 110.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2013 | 0.38 |
| Jan 31, 2013 | 0.33 |
| Oct 31, 2012 | 0.24 |
| Jul 31, 2012 | 0.13 |
| Apr 30, 2012 | 0.07 |
| Jan 31, 2012 | 0.06 |
| Oct 31, 2011 | 0.04 |
| Jul 31, 2011 | 0.03 |